bioRxiv preprint doi: https://doi.org/10.1101/2021.05.21.445170; this version posted May 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Coordinated regulation of CB1 cannabinoid receptors and anandamide metabolism stabilize network activity during homeostatic scaling down Abbreviated title: Endocannabinoids and Homeostatic Scaling-Down Michael Ye1, Sarah K. Monroe1, Sean M. Gay2, Michael L. Armstrong3, Diane E. Youngstrom1, Fabio L. Urbina1, Stephanie L. Gupton1,2, Nichole Reisdorph3, Graham H Diering1,2,4* Affiliations 1. Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 27599 2. UNC Neuroscience Center 3. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA 80045 4. Carolina Institute for Developmental Disabilities *Correspondence:
[email protected] Number of pages: 36 Number of figures: 6 Number of words: abstract (241), introduction (643), discussion (1483) Conflict of interest: The authors declare no competing financial interests Acknowledgements: This work was supported by a grant to GHD from the National Institutes of Health (RF1AG068063), and to SLG (R01NS112326). 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.05.21.445170; this version posted May 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Neurons express overlapping homeostatic mechanisms to regulate synaptic function and network properties in response to perturbations of neuronal activity. Endocannabinoids (eCBs) are bioactive lipids synthesized in the post-synaptic compartments that regulate synaptic transmission, plasticity, and neuronal excitability throughout much of the brain, by activating pre- synaptic cannabinoid receptor CB1.